Executive Order on Marijuana: President Trump signed an executive order to loosen federal regulations on marijuana, directing the U.S. Attorney General to expedite its rescheduling to Schedule III, which would allow for more research and medical use, though it stops short of full legalization.
Access to CBD Products: The order aims to improve access to hemp-derived CBD products by directing efforts to create a clear regulatory pathway through the FDA, while also restricting potentially harmful products.
Political Reactions: The decision received mixed reactions; Senate Minority Leader Chuck Schumer supported it as a positive step, while some Republicans criticized it as harmful to youth and a shortsighted policy.
Impact on Cannabis Stocks: Following the announcement, cannabis stocks initially surged but later retreated due to the lack of expected banking provisions, although many stocks have seen significant gains in anticipation of the order.
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 4.520
Low
Averages
High
Current: 4.520
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
